Serotonin transporter binding after recovery from eating disorders
- PMID: 17690869
- DOI: 10.1007/s00213-007-0896-7
Serotonin transporter binding after recovery from eating disorders
Abstract
Rationale: Several lines of evidence suggest that altered serotonin (5-HT) function persists after recovery from anorexia nervosa (AN) and bulimia nervosa (BN).
Objectives: We compared 11 subjects who recovered (>1 year normal weight, regular menstrual cycles, no binging or purging) from restricting-type AN (REC RAN), 7 who recovered from bulimia-type AN (REC BAN), 9 who recovered from BN (REC BN), and 10 healthy control women (CW).
Materials and methods: Positron emission tomography (PET) imaging with [11C]McN5652 was used to assess the 5-HT transporter (5-HTT). For [11C]McN5652, distribution volume (DV) values were determined using a two-compartment, three-parameter tracer kinetic model, and specific binding was assessed using the binding potential (BP, BP=DVregion of interest/DVcerebellum-1).
Results: After correction for multiple comparisons, the four groups showed significant (p<0.05) differences for [11C]McN5652 BP values for the dorsal raphe and antero-ventral striatum (AVS). Post-hoc analysis revealed that REC RAN had significantly increased [11C]McN5652 BP compared to REC BAN in these regions.
Conclusions: Divergent 5-HTT activity in subtypes of eating disorder subjects may provide important insights as to why these groups have differences in affective regulation and impulse control.
Comment in
-
Serotonin transporter binding in eating disorders.Psychopharmacology (Berl). 2008 Apr;197(3):519-20; author reply 521-2. doi: 10.1007/s00213-007-1046-y. Epub 2007 Dec 31. Psychopharmacology (Berl). 2008. PMID: 18165910 No abstract available.
Similar articles
-
Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.Psychiatry Res. 2013 Feb 28;211(2):160-8. doi: 10.1016/j.pscychresns.2012.06.010. Epub 2012 Nov 13. Psychiatry Res. 2013. PMID: 23154100 Free PMC article.
-
Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.Arch Gen Psychiatry. 2005 Sep;62(9):1032-41. doi: 10.1001/archpsyc.62.9.1032. Arch Gen Psychiatry. 2005. PMID: 16143735
-
Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.Neuropsychopharmacology. 2004 Jun;29(6):1143-55. doi: 10.1038/sj.npp.1300430. Neuropsychopharmacology. 2004. PMID: 15054474 Free PMC article.
-
Eating disorders: Do PET and SPECT have a role? A systematic review of the literature.Psychiatry Res Neuroimaging. 2020 Jun 30;300:111065. doi: 10.1016/j.pscychresns.2020.111065. Epub 2020 Mar 12. Psychiatry Res Neuroimaging. 2020. PMID: 32234640
-
Brain imaging of serotonin after recovery from anorexia and bulimia nervosa.Physiol Behav. 2005 Sep 15;86(1-2):15-7. doi: 10.1016/j.physbeh.2005.06.019. Physiol Behav. 2005. PMID: 16102788 Review.
Cited by
-
Neuroimaging in eating disorders.Neuropsychiatr Dis Treat. 2011;7:577-84. doi: 10.2147/NDT.S25186. Epub 2011 Sep 29. Neuropsychiatr Dis Treat. 2011. PMID: 22003297 Free PMC article.
-
Ketamine as a Treatment for Anorexia Nervosa: A Narrative Review.Nutrients. 2021 Nov 20;13(11):4158. doi: 10.3390/nu13114158. Nutrients. 2021. PMID: 34836413 Free PMC article. Review.
-
Serotonin transporter binding after recovery from bulimia nervosa.Int J Eat Disord. 2012 Apr;45(3):345-52. doi: 10.1002/eat.20944. Epub 2011 Jun 13. Int J Eat Disord. 2012. PMID: 21671458 Free PMC article.
-
Potential Differences in Psychedelic Actions Based on Biological Sex.Endocrinology. 2024 Jul 1;165(8):bqae083. doi: 10.1210/endocr/bqae083. Endocrinology. 2024. PMID: 38980913 Free PMC article. Review.
-
Imaging of the brain serotonin transporters (SERT) with 18F-labelled fluoromethyl-McN5652 and PET in humans.Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):1001-11. doi: 10.1007/s00259-012-2078-z. Epub 2012 Feb 17. Eur J Nucl Med Mol Imaging. 2012. PMID: 22349718 Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous